Waeber C, Zhang L A, Palacios J M
Preclinical Research Sandoz Pharma Ltd., Basel, Switzerland.
Brain Res. 1990 Oct 1;528(2):197-206. doi: 10.1016/0006-8993(90)91658-4.
The caudate-putamen, globus pallidus and substantia nigra pars reticulata of the guinea pig contain high densities of the 5-HT1D receptor subtype. The cellular localization of these sites in the striatonigral pathway was investigated using receptor autoradiography and selective neurotoxin lesions. In guinea pigs with unilateral 6-hydroxydopamine lesions of the nigral dopaminergic cells, no significant decrease was observed in any of the components of the striatonigral pathway. In contrast, when quinolinic acid was injected in the caudate-putamen, marked reductions in [3H]5-HT binding were seen in the caudate-putamen, the globus pallidus and the substantia nigra pars reticulata, on the side ipsilateral to the lesion. These data, which are comparable to previous results in human pathologies where similar cell populations are known to degenerate (Parkinson disease and Huntington's chorea), indicate a presynaptic localization of 5-HT1D receptors on the terminals of the striatal neurons projecting to the pars reticulata of the substantia nigra. In addition, these receptors could be located on the cell bodies or dendrites of these neurons in the striatum, postsynaptically to serotoninergic fibers.
豚鼠的尾状核 - 壳核、苍白球和黑质网状部含有高密度的5 - HT1D受体亚型。使用受体放射自显影术和选择性神经毒素损伤研究了这些位点在纹状体黑质通路中的细胞定位。在单侧黑质多巴胺能细胞6 - 羟基多巴胺损伤的豚鼠中,纹状体黑质通路的任何组成部分均未观察到明显减少。相反,当在尾状核 - 壳核中注射喹啉酸时,在损伤同侧的尾状核 - 壳核、苍白球和黑质网状部中观察到[3H]5 - HT结合显著减少。这些数据与先前在人类病理学中的结果相当,在已知类似细胞群会退化的情况下(帕金森病和亨廷顿舞蹈病),表明5 - HT1D受体在投射到黑质网状部的纹状体神经元终末上的突触前定位。此外,这些受体可能位于纹状体中这些神经元的胞体或树突上,位于5 - 羟色胺能纤维的突触后。